Am J Respir Crit Care Med

1. MCNAIR E, Valawalkar S, Cox S, Mave V, et al
   Reply to Liang et al.: Interpreting Post-Tuberculosis Lung Disease after Extrapulmonary Tuberculosis.
   Am J Respir Crit Care Med. 2026 Aug 12:aamag425. doi: 10.1093.
   

   >> Share

   
   
2. LIANG M, He J, Qu J
   Interpreting Post-Tuberculosis Lung Disease after Extrapulmonary Tuberculosis.
   Am J Respir Crit Care Med. 2026 Aug 12:aamag424. doi: 10.1093.
   

   >> Share

   
   

   
   Eur J Clin Microbiol Infect Dis

3. LEE JM, Kim HW, Lee EG, Park Y, et al
   Real-world treatment outcomes of a 6-month fluoroquinolone-containing regimen for isoniazid mono-resistant pulmonary tuberculosis in Korea.
   Eur J Clin Microbiol Infect Dis. 2026 Aug 13. doi: 10.1007/s10096-026-05629.
   

   >> Share

   
   

   
   J Clin Microbiol

4. KOMAKECH K, Sserwadda I, Sserubiri J, Joloba M, et al
   Head-to-head evaluation of host blood biomarkers for point-of-care TB triage: diagnostic accuracy study.
   J Clin Microbiol. 2026;64:e0004626.
   

   >> Share

   
   
5. SVENSSON E, Folkvardsen DB, Norman A, Rasmussen EM, et al
   Increased sensitivity of the updated FluoroType MTBDR V2 with addition of IS6110 analysis.
   J Clin Microbiol. 2026;64:e0026826.
   

   >> Share

   
   

   
   J Infect

6. ZHANG S, Qi J, Zheng J, Qin Y, et al
   National and subnational burden of HIV-negative MDR-TB in China, 1990-2023: Spatio-temporal heterogeneity, long-term trends, and projections.
   J Infect. 2026;93:106816.
   

   >> Share

   
   
7. DONOVAN J, Hung TT, Hiep NTT, Nghia HDT, et al
   A randomised comparison of management strategies for drug-induced liver injury associated with tuberculous meningitis treatment.
   J Infect. 2026;93:106796.
   

   >> Share

   
   

   
   J Infect Dis

8. TSAI CY, Xie M, Cristaldo M, Peluso GR, et al
   BCG vaccination with adjunctive APRIL immunotherapy reduces tuberculosis relapse in mice.
   J Infect Dis. 2026 Aug 12:jiag416. doi: 10.1093.
   

   >> Share

   
   
9. NORTIER E, Boczar MM, Hughes JA, van der Westhuizen JN, et al
   Pharmacokinetics and Safety of a Novel Clofazimine Formulation and Dosing Strategy in Children With Rifampicin-resistant Tuberculosis.
   J Infect Dis. 2026 Aug 13:jiag381. doi: 10.1093.
   

   >> Share

   
   
10. MARTINEZ-LOPEZ YE, Black BW, Lee J, Buta BJ, et al
    Frailty as a framework to understand tuberculosis severity, recovery and sequelae.
    J Infect Dis. 2026 Aug 14:jiag415. doi: 10.1093.
    

    >> Share

    
    

    
    N Engl J Med

11. YERLIKAYA S, Andama A, Cattamanchi A
    Tuberculosis Detection with MiniDock MTB. Reply.
    N Engl J Med. 2026;395:727-728.
    

    >> Share

    
    
12. ACOSTA-BATISTA C
    Tuberculosis Detection with MiniDock MTB.
    N Engl J Med. 2026;395:726.
    

    >> Share

    
    
13. BOYLES T
    Tuberculosis Detection with MiniDock MTB.
    N Engl J Med. 2026;395:726.
    

    >> Share

    
    

    
    PLoS One

14. NAGARAJAN K, Arangba S, Watson B, Malaisamy M, et al
    Tuberculosis Knowledge, Attitude, and Practice (TB-KAP) among the volunteers: Findings from community-based intervention training outcome in Tribal Hard-to-Reach Areas in Manipur.
    PLoS One. 2026;21:e0356469.
    

    >> Share

    
    
15. KALABA D, Chanda C, Mputu M, Benson HM, et al
    Determinants of favorable treatment outcomes in multidrug-resistant tuberculosis in Zambia: A retrospective cross sectional study, 2018-2022.
    PLoS One. 2026;21:e0355721.
    

    >> Share

    
    
16. 
    Correction: Tuberculosis in advanced chronic kidney disease: An Observational Study at a Tertiary Care Center in Mexico.
    PLoS One. 2026;21:e0356043.
    

    >> Share

    
    

    
    Proc Natl Acad Sci U S A

17. MCCAFFREY EF, Delmastro AC, Singh B, Devi A, et al
    Therapeutic remodeling of the tuberculosis granuloma with 1-methyl-D-tryptophan enhances CD8(+) T cell-macrophage interactions.
    Proc Natl Acad Sci U S A. 2026;123:e2528104123.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share